{"id":26714,"date":"2021-09-19T15:38:11","date_gmt":"2021-09-19T13:38:11","guid":{"rendered":"https:\/\/www.transgene.com\/?p=26714"},"modified":"2025-10-12T19:59:46","modified_gmt":"2025-10-12T17:59:46","slug":"jean-luc-belingard","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/jean-luc-belingard\/","title":{"rendered":"Jean-Luc B\u00c9LINGARD"},"content":{"rendered":"\n<p><img decoding=\"async\" class=\"imgMembers wp-image-18371 size-medium aligncenter\" src=\"..\/..\/wp-content\/uploads\/Belingard.jpg\" alt=\"Jean-Luc B\u00c9LINGARD\"><\/p>\n<p>Jean-Luc B\u00e9lingard a \u00e9t\u00e9 Pr\u00e9sident-Directeur g\u00e9n\u00e9ral de bioM\u00e9rieux SA de 2010 \u00e0 2017. Il est dipl\u00f4m\u00e9 de l\u2019Ecole des Hautes Etudes Commerciales de Paris (HEC \u2013 1971) et titulaire d\u2019un MBA de l\u2019Universit\u00e9 Cornell (Etats-Unis \u2013 1974). Il a occup\u00e9 de nombreuses fonctions de management au sein de grands groupes pharmaceutiques : de 1974 \u00e0 1983 chez Merck, Sharp &amp; Dome ; puis comme Pr\u00e9sident du directoire de 1983 \u00e0 1990 chez Roche France ; comme membre du comit\u00e9 ex\u00e9cutif de 1990 \u00e0 1998 chez F. Hoffman- La Roche Ltd. et Directeur g\u00e9n\u00e9ral de 1990 \u00e0 1998 de Roche Diagnostics \u00e0 B\u00e2le ; enfin comme Directeur G\u00e9n\u00e9ral de 1999 \u00e0 2001 de bioM\u00e9rieux \u2013 Pierre Fabre et Pr\u00e9sident-Directeur g\u00e9n\u00e9ral de 2002 \u00e0 2010 d\u2019Ipsen Group.<\/p>\n<p>Jean-Luc B\u00e9lingard est administrateur du conseil depuis 2013.<\/p>\n<p><strong><em>Comit\u00e9 :<\/em><\/strong> Pr\u00e9sident du comit\u00e9 de r\u00e9flexion strat\u00e9gique<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jean-Luc B\u00e9lingard a \u00e9t\u00e9 Pr\u00e9sident-Directeur g\u00e9n\u00e9ral de bioM\u00e9rieux SA de 2010 \u00e0 2017. Il est dipl\u00f4m\u00e9 de l\u2019Ecole des Hautes Etudes Commerciales de Paris (HEC \u2013 1971) et titulaire d\u2019un MBA de l\u2019Universit\u00e9 Cornell (Etats-Unis \u2013 1974). Il a occup\u00e9 de nombreuses fonctions de management au sein de grands groupes pharmaceutiques : de 1974 \u00e0&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/jean-luc-belingard\/\">Poursuivre la lecture <span class=\"screen-reader-text\">Jean-Luc B\u00c9LINGARD<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[111],"tags":[],"class_list":["post-26714","post","type-post","status-publish","format-standard","hentry","category-outils-profils","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Jean-Luc B\u00e9lingard a \u00e9t\u00e9 Pr\u00e9sident-Directeur g\u00e9n\u00e9ral de bioM\u00e9rieux SA de 2010 \u00e0 2017. Il est dipl\u00f4m\u00e9 de l\u2019Ecole des Hautes Etudes Commerciales de Paris (HEC \u2013 1971) et titulaire d\u2019un MBA de l\u2019Universit\u00e9 Cornell (Etats-Unis \u2013 1974). Il a occup\u00e9 de nombreuses fonctions de management au sein de grands groupes pharmaceutiques : de 1974 \u00e0&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=26714"}],"version-history":[{"count":2,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26714\/revisions"}],"predecessor-version":[{"id":38089,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/26714\/revisions\/38089"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=26714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=26714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=26714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}